Medical Communications

Vedanta Biosciences, a PureTech Health company developing a new class of therapies designed to modulate the human microbiome, has announced …

Merck Group has rebranded to “reflect its transformation into a science and technology company”, and restructured its business to create …

Boston-based biopharmaceutical company Berg recently announced it joined an industry collaboration with Genomics England, set up by UK Prime Minister …

The European Medicines Agency’s (EMA’s) Management Board has nominated Professor Guido Rasi as the Executive Director of the Agency. The …

Oncology groups such as the American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network (NCCN) are working …

Sanofi is looking for a deal with unions in order to boost productivity by 20-25% at French plants over three …

AstraZeneca has announced that Moventig (naloxegol) has been made available for adult patients with opioid-induced constipation (OIC) in England and …

Leading pharmaceutical companies, physicians, healthcare professionals, scientists, respiratory experts, and of course the media, including Pharmafocus, gathered in Amsterdam at the …

Ovid Therapeutics, a privately held biopharmaceutical company focused on developing therapies for rare and orphan diseases of the brain, has …

Diabetes UK and Novo Nordisk have announced the appointment of 20 Diabetes UK ‘Clinical Champions’, who will be supported and …

Cambridge, UK-based MISSION Therapeutics has announced the appointment of David Luther as chief financial officer.Luther brings more than 25 years’ …

The UK has ranked first in the 2015 Quality of Death Index, a measure of the quality of palliative care …

Millions of patients will benefit from ground-breaking plans for seven-day access to both their GPs and hospitals, British Prime Minister …

Hillary Clinton has taken aim at the pharmaceutical industry with a campaign advert airing in two US states, in which …

The global social network for physicians, SERMO, is partnering with Global Genes, a leading rare disease patient advocacy organisation, to provide …